CARS (Cardiac Amyloidosis Registry) - Clinical Trial
What is the Purpose of this Study?
Treatment
We are doing this study to see how different things, like medical and treatment history, affect outcomes in people with cardiac amyloidosis.
What is the Condition Being Studied?
Objective
Cardiac Amyloidosis
Who Can Participate in the Study?
Key Eligibility
Adults ages 18-89 who are diagnosed with Al or TTR cardiomyopathy.
For more information about who can join the study, please contact the study team at 919-681-7835.
Age Group
Adults
What is Involved?
Description
If you choose to join the study, you will:
- Review the consent form at an already scheduled doctor's appointment
- Give the study team permission to access your medical records
Study Details
Full Title
Cardiac Amyloidosis Registry Study
Principal Investigator
Cardiologist
Protocol Number
IRB:
PRO00107308
Enrollment Status
Open for Enrollment